Parathyroid surgery may improve life quality for kidney patients, study hints
NCT ID NCT07151664
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will examine how quality of life changes after parathyroid surgery in 60 adults with kidney failure and secondary hyperparathyroidism. Researchers will use a database to compare quality-of-life scores, anxiety, and depression before and after surgery. The goal is to better understand the benefits of this operation for patients on dialysis.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- parathyroidectomy (surgery to remove parathyroid glands)
- What this could lead to
- If successful, this study could help doctors better understand how parathyroid surgery affects quality of life in kidney failure patients, guiding future care decisions.
- What could go wrong
- This is a small, retrospective study (60 patients) that only looks back at existing data. It cannot prove cause and effect, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Sep 2025
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease were included in this study
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Age ≥18 years; Patients who had undergone parathyroidectomy for secondary hyperparathyroidism due to end-stage renal disease. Exclusion Criteria: Patients who underwent kidney transplantation during the study period. Patients with postoperative whole blood parathyroid hormone levels \>300 pg/mL within the first week after surgery. Patients with missing postoperative quality of life assessment data.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for End stage renal failure are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New vitamin d pill aims to tame parathyroid glands in dialysis patients
- Can changing dialysis times save Patients' legs?
- New nerve block could slash opioid use in Kids' kidney surgery
- Kidney transplant breakthrough: Biopsy-Guided drug adjustments could save grafts
- Tiny trial tests best way to create dialysis access
- CMV's hidden impact on transplant immunity under the microscope